Protocolized Initiation of Clonidine to Prevent Dexmedetomidine Withdrawal

PHASE4CompletedINTERVENTIONAL
Enrollment

128

Participants

Timeline

Start Date

October 8, 2022

Primary Completion Date

February 15, 2024

Study Completion Date

February 15, 2024

Conditions
Withdrawal; Therapeutic Substance
Interventions
DRUG

Clonidine (without protocolized initiation)

Participants will be observed for dexmedetomidine withdrawal and clonidine will be started at clinician discretion.

DRUG

Clonidine (protocolized initiation)

"* Observe participants without initiating clonidine with dexmedetomidine infusion time of 72-119 hours. To wean off dexmedetomidine, decrease the infusion by 25% of the starting dose every 6 hours.~* Begin clonidine at 1 mcg/kg enterally every 6 hours for participants with dexmedetomidine infusion time of 120-144 hours.~* Begin clonidine at 1.5 mcg/kg enterally every 6 hours for participants with dexmedetomidine infusion times of 145-167 hours.~* Begin clonidine at 2 mcg/kg enterally every 6 hours for participants with dexmedetomidine infusion time of \>/= 168 hours or with infusion time of 120-167 hours at doses \>/= 1.1 mcg/kg/min.~* If clonidine is started decrease the dexmedetomidine infusion by 25% of the starting dose 1 hour after each dose of clonidine until off (wean every 6 hours)."

Trial Locations (1)

77030

Children's Memorial Hermann Hospital, Houston

All Listed Sponsors
lead

The University of Texas Health Science Center, Houston

OTHER